Hikal announced the successful development of Favipiravir Active Pharmaceutical ingredient (API) and its intermediates the , In 5th wave after completing( i)st and ( ii)nd wave the ( iii)rd wave of 5th has a trg of 210.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.